Compared to Estimates, Leidos (LDOS) Q4 Earnings: A Look at Key Metrics

11.02.25 15:30 Uhr

Werte in diesem Artikel
Aktien

125,10 EUR 2,25 EUR 1,83%

Indizes

5.611,9 PKT 30,9 PKT 0,55%

For the quarter ended December 2024, Leidos (LDOS) reported revenue of $4.37 billion, up 9.7% over the same period last year. EPS came in at $2.37, compared to $1.99 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $4.12 billion, representing a surprise of +5.89%. The company delivered an EPS surprise of +8.72%, with the consensus EPS estimate being $2.18.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Leidos performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Health & Civil: $1.33 billion versus the three-analyst average estimate of $1.22 billion. Revenues- National Security and Digital: $1.89 billion versus the three-analyst average estimate of $1.81 billion. Revenues- Commercial & International: $604 million versus $565.04 million estimated by three analysts on average. Revenues- Defense Systems: $539 million compared to the $533.32 million average estimate based on three analysts. The reported number represents a change of -75.6% year over year. Operating income (loss)- Defense Systems: $2 million compared to the $33.94 million average estimate based on two analysts. Non-GAAP operating income (loss)- Defense Systems: $19 million versus $50.69 million estimated by two analysts on average. Operating income (loss)- National Security & Digital: $175 million versus the two-analyst average estimate of $183.34 million. Non-GAAP operating income (loss)- Health & Civil: $287 million versus $220.59 million estimated by two analysts on average. Non-GAAP operating income (loss)- National Security and Digital: $184 million versus $170.44 million estimated by two analysts on average. Non-GAAP operating income (loss)- Commercial & International: $48 million compared to the $46.24 million average estimate based on two analysts. Operating income (loss)- Health & Civil: $279 million compared to the $253.44 million average estimate based on two analysts. Operating income (loss)- Commercial & International: $40 million compared to the $30.33 million average estimate based on two analysts. View all Key Company Metrics for Leidos here>>>Shares of Leidos have returned -6.5% over the past month versus the Zacks S&P 500 composite's +4.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Leidos Holdings, Inc. (LDOS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Leidos und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Leidos

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Leidos

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Leidos Holdings Inc

Wer­bung

Analysen zu Leidos Holdings Inc

DatumRatingAnalyst
21.11.2017Leidos HoldStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
21.11.2017Leidos HoldStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Leidos Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen